Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL Meeting Abstract
| Authors: | Park, J. H.; Riviere, I.; Wang, X. Y.; Bartido, S.; Sadelain, M.; Brentjens, R. J. |
| Abstract Title: | Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203838 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.7020 |
| Notes: | Meeting Abstract: 7020 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
